InvestorsHub Logo
Followers 31
Posts 405
Boards Moderated 1
Alias Born 01/04/2023

Re: None

Tuesday, 01/31/2023 9:28:26 AM

Tuesday, January 31, 2023 9:28:26 AM

Post# of 1553
Avail Scientific Appoints Gerard Maynard as Chief Revenue Officer



Jan 31, 2023 (ACCESSWIRE via COMTEX) -- TORONTO, ON / ACCESSWIRE / January 31, 2023 / MOBILE LADS, CORP., dba AVAIL SCIENTIFIC (OTC PINK:MOBO), is pleased to announce Gerard Maynard as Chief Revenue Officer ("CRO"). Following Avail's January 10th, 2023, Letter of Intent that outlined the terms for the acquisition of Relai Neuro at which Gerard Maynard is currently President. Gerard has over twenty years of experience building, and leading successful sales organizations, in digital marketing, healthcare, technology and IT management.

"I couldn't be more thrilled to join such an amazing organization as Avail Scientific. With Avail's new venture into neurological testing, data management as well as strategic partnerships in the mental health industry. This is a golden opportunity to drive revenues via Avail's neurological testing and analytics while building our strategic partnerships and long-term value. Avail is poised to have exponential growth over the next few years. I feel very fortunate to be a party of such a talented team" statement from Gerard Maynard Relai Neuro provides neurological testing and data management to rehab and mental health treatment centers in Florida. Avail Scientific's (MOBO) mandate is to support psychedelic medicine research and treatments through neurological testing, data analytics, and data management.

Website: https://www.relaineuro.com

Website: https://www.availscientific.com/

https://www.marketwatch.com/press-release/avail-scientific-appoints-gerard-maynard-as-chief-revenue-officer-2023-01-31?mod=mw_quote_news_seemore